Bioregenx (BRGX) Assets Average (2023 - 2026)

Bioregenx's Assets Average history runs 4 years deep, the most recent figure standing at $374028.0 for Q1 2026.

• On a quarterly basis, Assets Average fell 24.53% year-over-year to $374028.0 in Q1 2026; TTM through Mar 2026 was $374028.0, a 24.53% decrease from a year earlier, with the FY2025 full-year figure at $459760.5, down 33.09% from the prior year.
• Assets Average slipped to $374028.0 in Q1 2026 per BRGX's latest filing, from $789375.0 in the prior quarter.
• Across five years, Assets Average topped out at $18.3 million in Q2 2024 and bottomed at $59743.5 in Q3 2023.
• The 4-year median for Assets Average is $789375.0 (2025), against an average of $4.5 million.
• Across the five-year window, Assets Average soared 29402.99% in 2024 and sank 95.53% in 2025, its largest moves.
• Year by year, Assets Average stood at $449865.5 in 2023, then surged by 1886.14% to $8.9 million in 2024, then plunged by 91.17% to $789375.0 in 2025, then plunged by 52.62% to $374028.0 in 2026.
• Per Business Quant, the three latest BRGX Assets Average figures stand at $374028.0 (Q1 2026), $789375.0 (Q4 2025), and $1.2 million (Q3 2025).